Intervention Review

Intravenous beta2-agonists versus intravenous aminophylline for acute asthma

  1. Andrew H Travers1,
  2. Arthur P Jones2,
  3. Carlos A Camargo Jr3,
  4. Stephen J Milan4,*,
  5. Brian H Rowe5,6

Editorial Group: Cochrane Airways Group

Published Online: 12 DEC 2012

Assessed as up-to-date: 28 SEP 2012

DOI: 10.1002/14651858.CD010256


How to Cite

Travers AH, Jones AP, Camargo Jr CA, Milan SJ, Rowe BH. Intravenous beta2-agonists versus intravenous aminophylline for acute asthma. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD010256. DOI: 10.1002/14651858.CD010256.

Author Information

  1. 1

    Emergency Health Services, Department of Emergency Medicine and Community Health and Epidemiology, Nova Scotia, Canada

  2. 2

    c/o Cochrane Airways Group, London, UK

  3. 3

    Massachusetts General Hospital, Department of Emergency Medicine, Boston, Massachusetts, USA

  4. 4

    St George's, University of London, Population Health Sciences and Education, London, UK

  5. 5

    University of Alberta, Department of Emergency Medicine, Edmonton, Alberta, Canada

  6. 6

    University of Alberta, School of Public Heath, Edmonton, Canada

*Stephen J Milan, Population Health Sciences and Education, St George's, University of London, London, UK. smilan@sgul.ac.uk. milanstephen1@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 12 DEC 2012

SEARCH